CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.540
EU - Europa 6.566
AS - Asia 5.717
SA - Sud America 758
AF - Africa 122
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.367
SE - Svezia 2.164
SG - Singapore 1.872
CN - Cina 1.590
GB - Regno Unito 1.587
IT - Italia 930
HK - Hong Kong 816
BR - Brasile 576
VN - Vietnam 494
DE - Germania 472
FI - Finlandia 398
FR - Francia 219
RU - Federazione Russa 214
TR - Turchia 209
UA - Ucraina 194
KR - Corea 181
IN - India 115
ID - Indonesia 88
BG - Bulgaria 85
CA - Canada 79
AR - Argentina 76
NL - Olanda 63
MX - Messico 59
AU - Australia 54
IQ - Iraq 47
BD - Bangladesh 39
JP - Giappone 33
ZA - Sudafrica 32
IE - Irlanda 29
EC - Ecuador 28
EG - Egitto 27
PL - Polonia 25
RO - Romania 25
VE - Venezuela 25
AT - Austria 22
BE - Belgio 22
ES - Italia 22
MY - Malesia 22
AE - Emirati Arabi Uniti 21
SA - Arabia Saudita 20
LT - Lituania 19
PH - Filippine 19
PK - Pakistan 19
UZ - Uzbekistan 17
CO - Colombia 16
DK - Danimarca 15
IR - Iran 15
MA - Marocco 14
TN - Tunisia 14
CL - Cile 13
IL - Israele 13
JO - Giordania 13
QA - Qatar 11
TH - Thailandia 11
CZ - Repubblica Ceca 10
AZ - Azerbaigian 9
CH - Svizzera 9
NP - Nepal 9
DO - Repubblica Dominicana 8
KE - Kenya 8
PE - Perù 8
GR - Grecia 7
MK - Macedonia 6
PY - Paraguay 6
RS - Serbia 6
TW - Taiwan 6
UY - Uruguay 6
CR - Costa Rica 5
HN - Honduras 5
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
KG - Kirghizistan 4
OM - Oman 4
AL - Albania 3
AO - Angola 3
BF - Burkina Faso 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
KZ - Kazakistan 3
PT - Portogallo 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
JM - Giamaica 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
Totale 23.741
Salva come PNG Salva come JPEG
Città #
Stockholm 1.785
Singapore 1.271
Santa Clara 1.106
Southend 1.062
Ashburn 955
Fairfield 889
Hong Kong 794
Chandler 659
Woodbridge 642
San Jose 603
Hefei 599
Houston 444
Jacksonville 390
Seattle 346
Wilmington 334
Cambridge 321
Helsinki 313
Dearborn 297
Beijing 271
Ann Arbor 255
London 254
Nyköping 243
Seoul 178
Cincinnati 170
Ho Chi Minh City 154
Los Angeles 152
Modena 130
Hanoi 119
Council Bluffs 115
New York 114
The Dalles 113
Izmir 112
San Diego 103
Princeton 92
Chicago 90
Bremen 83
Sofia 82
Lauterbourg 80
Eugene 70
Milan 68
Jakarta 66
Moscow 65
Grafing 61
Des Moines 57
Buffalo 56
Munich 52
Shanghai 50
São Paulo 48
Orem 45
Dallas 42
Melbourne 42
Falls Church 41
Rome 35
Salt Lake City 34
Bologna 33
Reggio Emilia 31
Columbus 30
Frankfurt am Main 29
Nuremberg 29
Kent 28
Parma 27
Haiphong 26
Phoenix 26
Dublin 25
Tokyo 25
Boardman 24
Amsterdam 22
Guangzhou 22
Montreal 22
Da Nang 21
Elk Grove Village 20
Brussels 19
Nanjing 19
Redwood City 19
Atlanta 18
Brooklyn 18
Johannesburg 18
Mexico City 17
Mumbai 17
Warsaw 17
Baghdad 16
Chennai 16
Denver 15
Manchester 15
Ottawa 15
Rio de Janeiro 15
Tampa 15
Timisoara 15
Norwalk 14
Poplar 14
Toronto 14
Belo Horizonte 13
Fremont 13
Redondo Beach 13
San Francisco 13
Turku 13
Verona 13
Falkenstein 12
Kunming 12
Miano 12
Totale 17.432
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.047
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 524
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 453
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 395
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 359
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 350
Management of bone disease in Gaucher disease type 1: clinical practice 346
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 345
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 344
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 343
Nutrition in adult patients with selected lysosomal storage diseases 339
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 329
Growth of human herpesvirus 6 in HepG2 cells 323
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 309
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 305
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 305
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 301
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 300
Cholesterol esterase activity of human intestinal mucosa 296
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 294
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 293
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 288
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 282
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 280
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 279
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 273
Anatomia e fisiologia delle vie biliari 269
Review article: effect of bile salt pool composition on hepatic and biliary functions 261
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 260
Bile acid structure and regulation of biliary protein secretion and composition in man 258
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 256
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 255
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 251
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 251
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 250
Fabry disease: raising awareness of the disease among physicians 250
Global multi-stakeholder endorsement of the MAFLD definition 247
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 245
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 241
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 240
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 239
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 239
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 238
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 235
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 234
Nonalcoholic fatty liver disease induced by leuprorelin acetate 233
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 231
Bile acid and hepatocyte death 226
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 220
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 219
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 215
Cholesterol Esterase Activity of human intestinal mucosa 214
Cholesterol esterase activity of human intestinal mucosa 214
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 211
Minimal disease activity in Gaucher disease: criteria for definition 211
Gaucher Disease in Bone: From Pathophysiology to Practice 200
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 199
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 195
Prevalence rates of gallstone disease in Italy: the Chianciano population study 188
Regulation of cholesterol absorption in humans 187
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 183
Patogenesi della colelitiasi 182
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 182
Hyperferritinemia and diagnosis of type 1 Gaucher disease 180
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 177
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 176
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 173
Nuove prospettive terapeutiche con acidi biliari. 170
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 169
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 168
Inquadramento delle sindromi colestatiche. 167
Regulation of bile acid synthesis in humans 165
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 165
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 164
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 162
Cholesterol esterase activity in the small bowel of humans 161
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 158
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 158
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 154
Malattie delle vie biliari 148
LA SECREZIONE LIPIDICA BILIARE 147
Liver metastases from carcinoid tumor: Imaging patterns 146
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 144
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 132
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 132
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 131
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 130
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 129
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 128
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 127
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 124
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 108
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 107
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 105
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 102
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 99
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 99
Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement 94
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 90
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 85
Totale 23.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 0 106 101
2021/20221.764 89 202 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20254.140 134 54 61 279 750 581 343 211 353 205 543 626
2025/20268.930 484 339 643 781 1.062 597 1.140 346 2.548 775 215 0
Totale 23.905